A recent study reveals that genetically modified bacteria can significantly speed up the weathering of olivine, a silicate mineral, enhancing its potential for carbon dioxide removal from the atmosphere.
The AIntibody challenge has revealed significant insights into AI-driven antibody design, highlighting both successes and limitations in computational methods.
Personalized medicine represents a paradigm shift in healthcare, focusing on tailoring treatments based on individual genetic profiles. This approach leverages advancements in genomics and biotechnology to enhance therapeutic efficacy and minimize adverse effects.
As genetic modification technologies advance, the ethical implications become increasingly complex. This exploration delves into the balance between scientific innovation and moral responsibility, examining the mechanisms, trade-offs, and real-world applications of genetic editing.
Research from the University of Wisconsin-Madison explores how bacteriophages modified in space could combat antibiotic-resistant bacteria, offering a glimpse into the future of biotechnological advancements.
The UK plans to phase out animal testing by 2027, driven by advancements in organ-on-chip technology and AI, marking a significant shift in research ethics.
